Search research articles
Contact Us
Filters
Showing results (171-180 of 178) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 178 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
T Conroy, P L Etienne, A Adenis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
M J van den Bent, W Grisold, D Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952
C-H Köhne, J Wils, M Lorenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
Journal of Neurosurgery
|
October 8, 2021
5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study
Alexander J Schupper, Rebecca B Baron, William Cheung, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 178) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 178 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
T Conroy, P L Etienne, A Adenis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
M J van den Bent, W Grisold, D Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952
C-H Köhne, J Wils, M Lorenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
Journal of Neurosurgery
|
October 8, 2021
5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study
Alexander J Schupper, Rebecca B Baron, William Cheung, et al.
Page
of 18